ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,996.66
      1.00%
      US Tech 100
      20,877.20
      1.72%
      Dow Jones
      43,487.83
      0.78%
      Brent Oil
      80.005
      0.00%
      Bitcoin
      104,664.53
      0.23%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Canada
      5. TSX

      6. Satellos Bioscience Inc (MSCL) Quote

      Satellos Bioscience Inc

      Satellos Bioscience Inc (MSCL)

      Satellos Bioscience Inc
      0.82
      -0.01
      (-1.20%)
      Closed January 19 4:12PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      0.82
      Bid
      0.82
      Ask
      0.83
      Volume
      53,010
      0.81 Day's Range 0.84
      0.38 52 Week Range 1.32
      Market Cap
      92.489M
      Previous Close
      0.83
      Open
      0.82
      Last Trade
      8000
      @
      0.82
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      147,427
      Shares Outstanding
      112,792,000
      Dividend Yield
      -
      PE Ratio
      -5.82
      Earnings Per Share (EPS)
      -0.14
      Revenue
      -
      Net Profit
      -15.89M

      About Satellos Bioscience Inc

      Sector
      Coml Physical, Biologcl Resh
      Industry
      Pharmaceutical Preparations
      Website
      www.satellos.com
      Headquarters
      Toronto, Ontario, Can
      Founded
      2007
      Satellos Bioscience Inc is listed in the Coml Physical, Biologcl Resh sector of the Toronto Stock Exchange with ticker MSCL. The last closing price for Satellos Bioscience was $0.83. Over the last year, Satellos Bioscience shares have traded in a share price range of $ 0.38 to $ 1.32.

      Satellos Bioscience currently has 112,792,000 shares outstanding. The market capitalization of Satellos Bioscience is $93.62 million. Satellos Bioscience has a price to earnings ratio (PE ratio) of -5.82.

      Ask ADVFN Intelligence (AI)

      MSCL Latest News

      More News

      L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - MSCL

      L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - MSCL Canada NewsWire TORONTO, le 17 déc. 2024 TORONTO, le 17 déc. 2024 /CNW/...

      December 17 2024
      PR Newswire (Canada)

      Canadian Investment Regulatory Organization Trade Resumption - MSCL

      Canadian Investment Regulatory Organization Trade Resumption - MSCL Canada NewsWire TORONTO, Dec. 17, 2024 TORONTO, Dec. 17, 2024 /CNW/ - Trading resumes in: Company: Satellos Bioscience...

      December 17 2024
      PR Newswire (Canada)

      Suspension de la négociation par l'Organisme canadien de réglementation des investissements - MSCL

      Suspension de la négociation par l'Organisme canadien de réglementation des investissements - MSCL Canada NewsWire TORONTO, le 16 déc. 2024 TORONTO, le 16 déc. 2024 /CNW/...

      December 16 2024
      PR Newswire (Canada)

      Canadian Investment Regulatory Organization Trading Halt - MSCL

      Canadian Investment Regulatory Organization Trading Halt - MSCL Canada NewsWire TORONTO, Dec. 16, 2024 TORONTO, Dec. 16, 2024 /CNW/ - The following issues have been halted by CIRO: Company:...

      December 16 2024
      PR Newswire (Canada)

      Satellos Announces First Participant with Duchenne Muscular Dystrophy Dosed in the Phase 1b Clinical Trial of SAT-3247

      - Marks successful completion of full enrollment of SAD cohorts and the first two MAD cohorts in the healthy volunteer study - Up to 10 adult participants with genetically confirmed Duchenne...

      December 11 2024
      Business Wire

      Satellos to Participate in Oppenheimer Movers in Rare Disease Summit

      Satellos Bioscience Inc. (TSX:MSCL, OTCQB:MSCLF) (“Satellos”), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and...

      December 03 2024
      Business Wire

      Satellos to Participate in Duchenne KOL Investor Webinar on December 4, 2024

      Satellos Bioscience Inc. (TSX:MSCL, OTCQB:MSCLF) ("Satellos" or the "Company"), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle...

      December 02 2024
      Business Wire

      Satellos Appoints Stephanie Brown to Board of Directors

      Satellos Bioscience Inc. (TSX: MSCL) (OTCQB: MSCLF) (“Satellos” or the “Company”), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle...

      November 14 2024
      Business Wire

      Satellos Reports Q3 2024 Financial Results and Provides Clinical Update

      - Completed enrollment for SAT-3247 in Duchenne muscular dystrophy (DMD) in the first three (of five) single-ascending dose (SAD) cohorts with no safety concerns and initiated enrollment of first...

      November 13 2024
      Business Wire

      Satellos to Participate in November 2024 Investor Conferences

      Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSX: MSCL) (OTCQB: MSCLF), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle...

      November 04 2024
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.03-3.529411764710.850.860.81183140.83223294CS
      4-0.01-1.204819277110.830.890.811082170.86499106CS
      120.079.333333333330.751.320.671474270.88105912CS
      260.32565.65656565660.4951.320.451120650.76754255CS
      520.232.25806451610.621.320.38909590.69389415CS
      1560.232.25806451610.621.320.38909590.69389415CS
      2600.232.25806451610.621.320.38909590.69389415CS

      MSCL - Frequently Asked Questions (FAQ)

      What is the current Satellos Bioscience share price?
      The current share price of Satellos Bioscience is $ 0.82
      How many Satellos Bioscience shares are in issue?
      Satellos Bioscience has 112,792,000 shares in issue
      What is the market cap of Satellos Bioscience?
      The market capitalisation of Satellos Bioscience is CAD 93.62M
      What is the 1 year trading range for Satellos Bioscience share price?
      Satellos Bioscience has traded in the range of $ 0.38 to $ 1.32 during the past year
      What is the PE ratio of Satellos Bioscience?
      The price to earnings ratio of Satellos Bioscience is -5.82
      What is the reporting currency for Satellos Bioscience?
      Satellos Bioscience reports financial results in CAD
      What is the latest annual profit for Satellos Bioscience?
      The latest annual profit of Satellos Bioscience is CAD -15.89M
      What is the registered address of Satellos Bioscience?
      The registered address for Satellos Bioscience is 79 WELLINGTON STREET WEST, 33RD FLOOR, TORONTO, ONTARIO, M5K 1N2
      What is the Satellos Bioscience website address?
      The website address for Satellos Bioscience is www.satellos.com
      Which industry sector does Satellos Bioscience operate in?
      Satellos Bioscience operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      BABYElse Nutrition Holdings Inc
      $ 0.035
      (40.00%)
      		2.33M
      DIAMStar Diamond Corporation
      $ 0.025
      (25.00%)
      		290.11k
      ELREastern Platinum Limited
      $ 0.15
      (20.00%)
      		58k
      PNC.APostmedia Network Canada Corp
      $ 1.30
      (18.18%)
      		400
      PNC.BPostmedia Network Canada Corp
      $ 1.41
      (17.50%)
      		855
      CNTCentury Global Commodities Corporation
      $ 0.025
      (-16.67%)
      		27k
      OPTOptiva Inc
      $ 4.50
      (-13.46%)
      		2.28k
      APLIAppili Therapeutics Inc
      $ 0.035
      (-12.50%)
      		8.48k
      COPRCoppernico Metals Inc
      $ 0.22
      (-12.00%)
      		332.26k
      ELEFSilver Elephant Mining Corp
      $ 0.165
      (-10.81%)
      		276.23k
      WNDRWonderFi Technologies Inc
      $ 0.35
      (6.06%)
      		15.9M
      TDToronto Dominion Bank
      $ 83.15
      (4.46%)
      		12.47M
      CNQCanadian Natural Resources Ltd
      $ 45.02
      (1.56%)
      		7.7M
      PPLPembina Pipeline Corporation
      $ 54.20
      (1.61%)
      		6.36M
      BCEBCE Inc
      $ 33.49
      (1.98%)
      		5.44M

      Discussion

      View Full Feed
      bar1080 bar1080 3 minutes ago
      I've attempted twice to understand Prof Joshua Mitts' shorting arguments, once around 2018 when it debuted and again last night. But I'm no Yale/Columbia PhD.

      Mitts assumes there are many activist short sellers. I only know of about five of them in the US, and Block and Left have bee
      Enterprising Investor Enterprising Investor 3 minutes ago
      Nuveen Intermediate Duration Quality Municipal Term Fund Liquidating Trust Announces Final Distribution and Termination (1/02/25)

      The final per unit distribution that is payable to all unitholders: $0.4550.

      As announced in June 2023, Nuveen Intermediate Duration Quality
      NIQ
      HGilS HGilS 3 minutes ago
      Elite is impacted too?
      ELTP
      capgain capgain 4 minutes ago
      The line moved on mine to 7 and 43
      Flobewan Flobewan 4 minutes ago
      I sent that one on, LOLOL
      toohot toohot 4 minutes ago
      LOL, I know the feeling because when I tried logging onto sales-track, I was infected by a virus. Thank you Norton fix.
      Enough of that, now for the rest of 2025, prepare for the accent of BIEL. Oops I mean excuse me. I MEANT ASCENT.
      ‘Nuff said!



      BIEL
      Hopeforthefuture3 Hopeforthefuture3 5 minutes ago
      Ex, unless one is a politician can't have it both ways
      NWBO
      learningcurve2020 learningcurve2020 5 minutes ago
      Advent’s working on a reformulation. $$$ 🙄
      NWBO
      Turbomunkey Turbomunkey 5 minutes ago
      Good morning Trooper. Thank you for the response and the link. #3 is pretty exciting. Lets see how the stock responds to this increased popularity. Good luck everyone.
      ILLR
      sortagreen sortagreen 7 minutes ago
      In a Tesla! 👍️
      exwannabe exwannabe 8 minutes ago
      And it is a fact that if ORR is not being shown by DCVax then running future trials based on ORR is kind if a problem.

      Why are you happy NWBO will be focusing on trials showing an endpoint that you do not think matters?
      NWBO
      Myth Myth 8 minutes ago
      I'm still on weather watch, it's snowing here now....

      I think the Eagles D will be swarming regardless..

      GL
      jimr1717 jimr1717 9 minutes ago
      100% Correct
      HMBL
      sharkey1 sharkey1 9 minutes ago
      THX James, sounds like they are selling every pill they can make.
      ELTP
      Trooperstocks Trooperstocks 9 minutes ago
      NEWS: TikTok “Refugees” Flock to U.S. Owned Rival, Triller
      January 18, 2025
      (Nasdaq: ILLR) Triller Corp

      https://trillercorp.com/wp-content/uploads/2024/09/Triller-App-Zoom.jpg

      In a remarkable shift in the social media landscape, Triller, the U.S.-owned sho
      ILLR
      Viking61 Viking61 11 minutes ago
      Sorry but I did mean preferred’s. Neither common or preferred classes will receive back dividends repaid because they have been in conservatorship. That’s why I’m on the commons side of the ledger for exponential gains through share price appreciation! The only thing that we’re going to get is the L
      FNMA
      HoldHigh HoldHigh 12 minutes ago
      I saw a post that says rivers was invited to attend trumps inauguration. I don't have any other information than that. If true, that will be interesting. It shows she has some contacts fairly high up.

      TSX:CURA - Post by User
      Curaleaf Holdings Inc
      TCNNF
      XMaster2023 XMaster2023 12 minutes ago
      Apparently EX and Theory have the same lack of retention. The answer is extracted again

      This aligns with the broader understanding in oncology that immunotherapies can result in delayed but durable responses and improved survival outcomes, even in the absence of measurable ORR.
      NWBO
      Trooperstocks Trooperstocks 13 minutes ago
      Top 3 App Downloaded says it all turbomunkey. No doubt Triller Corp. is helping Creators Transfer accounts and Working on the Release of the New 5.0 App.
      ILLR
      DocLee DocLee 13 minutes ago
      I recall that years ago, well before Top Line Data was published, it was discussed in this forum that NWBO was already in talks with NICE. I cannot believe that for all this time Management has been sitting on its collective backside since then having no further contact with NICE to agree a mutuall
      NWBO
      TommyJ7651 TommyJ7651 14 minutes ago
      Could be possible if the supply of physical silver is suddenly facing a hard squeeze. Keep in mind First Majestic produces some 50% of their production as gold as well, so any potential buyer would get that as part of the deal. I would still be quite surprised if this was the eventual outcome but fo
      FFMGF
      tredenwater2 tredenwater2 14 minutes ago
      Having the FDA guideline in draft, with the draft only changed last year to drop the ADL co-primary in early AD, puts the FDA decisional criteria in question until the draft goes final.

      With the peer reviewed paper and EMA eminent approval, these two will definitely force the FDA dra
      AVXL
      Participation_trophy_inc Participation_trophy_inc 15 minutes ago
      I have been searching Vietnamese websites about the nuclear energy agreement between Vietnam and Russia trying to find out if PGG is officially included or working behind the screens. If and when the $12.5 billion dollars is reflected in the account this is they type of project Henry could play a k
      PHIL
      LakeshoreLeo1953 LakeshoreLeo1953 17 minutes ago
      Your 21 “supporters” may be more than those clapping for Missling @ JPM.
      JPM
      NomadAstronaut241 NomadAstronaut241 18 minutes ago
      Does the guy run this out of his garage?
      ZENA

      Your Recent History

      TSX
      MSCL
      Satellos Bioscience
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads